Inhibition of adipogenesis by oligonol through Akt-mTOR inhibition in 3T3-L1 adipocytes

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Park, Jae Yeo ^a,b   Kim, Younghwa ^c   Im, Jee Ae ^d   You, Seungkwon ^b   Lee, Hyangkyu ^a  

^a Yonsei University   (South Korea)

^b Korea University   (South Korea)

^c Kyungil University   (South Korea)

^d INTOTO Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN DELTA; LIPID; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; OLIGONOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 84934778030     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/895272     Document Type: Article

References (35)

1. Z. Cao, R. M. Umek, and S. L.McKnight, "Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells," Genes and Development, vol. 5, no. 9, pp. 1538-1552, 1991.
2. F. M. Gregoire, "Adipocyte differentiation: From fibroblast to endocrine cell," Experimental Biology andMedicine, vol. 226, no. 11, pp. 997-1002, 2001.
3. O. I. Aruoma, B. Sun, H. Fujii, and et al, "Low molecular proanthocyanidin dietary biofactor Oligonol: Itsmodulation of oxidative stress, bioefficacy, neuroprotection, food application and chemoprevention potentials," BioFactors, vol. 27, no. 1-4, pp. 245-265, 2006.
4. H. Fujii, T. Yokozawa, Y. A. Kim, C. Tohda, and G.-I. Nonaka, "Protective effect of grape seed polyphenols against high glucose-induced oxidative stress," Bioscience, Biotechnology and Biochemistry, vol. 70, no. 9, pp. 2104-2111, 2006.
5. H. Fujii, B. Sun, H. Nishioka, A. Hirose, and O. I. Aruoma, "Evaluation of the safety and toxicity of the oligomerized polyphenol Oligonol," Food and Chemical Toxicology, vol. 45, no. 3, pp. 378-387, 2007.
6. T. Sakurai, H. Nishioka, H. Fujii et al., "Antioxidative effects of a new lychee fruit-derived polyphenol mixture, oligonol, converted into a low-molecular formin adipocytes," Bioscience, Biotechnology and Biochemistry, vol. 72, no. 2, pp. 463-476, 2008.
7. J. Ogasawara, K. Kitadate, H. Nishioka et al., "Oligonol, a new lychee fruit-derived low-molecular form of polyphenol, enhances lipolysis in primary rat adipocytes through activation of the ERK1/2 pathway," Phytotherapy Research, vol. 23, no. 11, pp. 1626-1633, 2009.
8. F. M. Gregoire, C. M. Smas, and H. S. Sul, "Understanding adipocyte differentiation," Physiological Reviews, vol. 78, no. 3, pp. 783-809, 1998.
9. B.D.Manning and L. C. Cantley, "AKT/PKB Signaling: Navigating Downstream," Cell, vol. 129, no. 7, pp. 1261-1274, 2007.
10. M. Thirunavukkarasu, L. Zhan, K. Wakame, H. Fujii, H. Moriyama, and M. Bagchi, "Safety of oligonol, a highly bioavailable lychee-derived polyphenolic antioxidant, on liver, kidney and heart function in rats," Toxicology Mechanisms and Methods, vol. 22, no. 7, pp. 555-559, 2012.
11. X. Zhao, L. Gan, H. Pan et al., "Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: Characterization of phosphorylation-and 14-3-3-dependent and-independent mechanisms," Biochemical Journal, vol. 378, part 3, pp. 839-849, 2004.
12. H. Guo, M. Xia, T. Zou, W. Ling, R. Zhong, and W. Zhang, "Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1," Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 349-360, 2012.
13. H. Fujii, H. Nishioka, K. Wakame, B. A. Magnuson, and A. Roberts, "Acute, subchronic and genotoxicity studies conducted with Oligonol, an oligomerized polyphenol formulated from lychee and green tea extracts," Food and Chemical Toxicology, vol. 46, no. 12, pp. 3553-3562, 2008.
14. J. Söhle, A. Knott, U. Holtzmann et al., "White Tea extract induces lipolytic activity and inhibits adipogenesis in human subcutaneous (pre)-adipocytes," Nutrition and Metabolism, vol. 6, article 20, 2009.
15. G. S. Kim, H. J. Park, J. H. Woo et al., "Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells," BMC Complementary and Alternative Medicine, vol. 12, article 31, 2012.
16. C. Andersen, S. Rayalam, M. A. Della-Fera, and C. A. Baile, "Phytochemicals and adipogenesis," BioFactors, vol. 36, no. 6, pp. 415-422, 2010.
17. E. Gouranton, G. Aydemir, E. Reynaud et al., "Apo-10-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors," Biochimica et Biophysica Acta, vol. 1811, no. 12, pp. 1105-1114, 2011.
18. J. Ogasawara, K. Kitadate, H. Nishioka et al., "Comparison of the effect of oligonol, a new lychee fruit-derived low molecular form of polyphenol, and epigallocatechin-3-gallate on lipolysis in rat primary adipocytes," Phytotherapy Research, vol. 25, no. 3, pp. 467-471, 2011.
19. A. Baudry, Z.-Z. Yang, and B. A. Hemmings, "PKB is required for adipose differentiation of mouse embryonic fibroblast," Journal of Cell Science, vol. 119, part 5, pp. 889-897, 2006.
20. H. H. Zhang, J. Huang, K. Düvel et al., "Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway," PLoS ONE, vol. 4, no. 7,Article ID e6189, 2009.
21. J. Xu and K. Liao, "Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation," Journal of Biological Chemistry, vol. 279, no. 34, pp. 35914-35922, 2004.
22. C. A. Grimes and R. S. Jope, "The multifaceted roles of glycogen synthase kinase 3 in cellular signaling," Progress in Neurobiology, vol. 65, no. 4, pp. 391-426, 2001.
23. S. E. Ross, R. L. Erickson, N. Hemati, and O. A. MacDougald, "Glycogen synthase kinase 3 is an insulin-regulated C/EBP kinase,"Molecular and Cellular Biology, vol. 19, no. 12, pp. 8433-8441, 1999.
24. J. E. Kim and J. Chen, "Regulation of peroxisome proliferatoractivated receptor- activity bymammalian target of rapamycin and amino acids in adipogenesis," Diabetes, vol. 53, no. 11, pp. 2748-2756, 2004.
25. A. Bell, L. Grunder, and A. Sorisky, "Rapamycin inhibits human adipocyte differentiation in primary culture," Obesity Research, vol. 8, no. 3, pp. 249-254, 2000.
26. W. C. Yeh, B. E. Bierer, and S. L.McKnight, "Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 24, pp. 11086-11090, 1995.
27. I. Kim and Y. Y. He, "Targeting the AMP-activated protein kinase for cancer prevention and therapy," Frontiers inOncology, vol. 3, article 175, 2013.
28. Y. K. Lee, W. S. Lee, G. S. Kim, and O. J. Park, "Anthocyanins are novel AMPK1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation," Oncology Reports, vol. 24, no. 6, pp. 1471-1477, 2010.
29. N. Khan, F. Afaq, F. H. Khusro, V. Mustafa Adhami, Y. Suh, and H. Mukhtar, "Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin," International Journal of Cancer, vol. 130, no. 7, pp. 1695-1705, 2012.
30. Y. Suh, F. Afaq, N. Khan, J. J. Johnson, F. H. Khusro, and H. Mukhtar, "Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells," Carcinogenesis, vol. 31, no. 8, pp. 1424-1433, 2010.
31. Y. K. Lee, W. S. Lee, J. T. Hwang, D. Y. Kwon, Y. J. Surh, and O. J. Park, "Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells," Journal of Agricultural and Food Chemistry, vol. 57, no. 1, pp. 305-310, 2009.
32. C. Brattström,H.Wilczek, G. Tydén, Y. Böttiger, J. Säwe, andC.-G.Groth, "Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)," Transplantation, vol. 65, no. 9, pp. 1272-1274, 1998.
33. C. Brattström, H. E. Wilczek, G. Tydén, Y. Böttiger, J. Säwe, and C. G. Groth, "Hypertriglyceridemia in renal transplant recipients treated with Sirolimus," Transplantation Proceedings, vol. 30, no. 8, pp. 3950-3951, 1998.
34. M. Roland, P. Gatault, C. Doute et al., "Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation," Transplant International, vol. 21, no. 6, pp. 523-530, 2008.
35. D. W. Lamming, L. Ye, P. Katajisto et al., "Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity," Science, vol. 335, no. 6076, pp. 1638-1643, 2012.